Delivery Order SPE2DB25D9363-SPE2DB25FUFSE
- Not listed
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $51,760.32, is for the delivery of ILARIS 150 mg/mL vials to support the medical supply needs of military health facilities. The award is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA, valued up to $499,999,999, which allows the agency to...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $25,655.02 and a completion date of January 30, 2025. It is not associated with any set-aside designation. The contract covers the delivery of ILARIS 150 MG/ML VIALML, a specialized pharmaceutical product, to support the medical supply needs of...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $53,150.28 contract is for the delivery of 4565562910 - ILARIS 150 MG/ML VIALML, with a period of performance through September 11, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of ILARIS 150 MG/ML VIALML, with a ceiling value of $76,965.06 and an ultimate completion date of June 11, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $25,655.02 and covers the delivery of ILARIS 150 MG/ML VIALML, a specialized pharmaceutical product, to support the recurring medical supply needs of military healthcare facilities. The contract is not associated with any set-aside designation,...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $12,827.51, is for the provision of ILARIS 150 MG/ML VIALML, a specialized pharmaceutical product. The contract has an ultimate completion date of February 12, 2025 and is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery...
- This is a $26,575.14 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of ILARIS 150 MG/ML VIALML, a pharmaceutical product, to support the recurring medical supply needs of military health facilities. The award is not associated with a set-aside program. DMS Pharmaceutical Group holds a larger $499,999,999...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $26,575.14 contract is for the delivery of ILARIS 150 MG/ML VIALML, a pharmaceutical product, with a completion date of June 25, 2024. The contract is not associated with a set-aside program. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract has a potential value of $13,287.57 and a completion date of February 9, 2024. It is not associated with a set-aside program. The contract requires DMS Pharmaceutical Group to supply the DLA with the pharmaceutical product ILARIS 150 MG/ML VIALML. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $25,655.02, is for the provision of ILARIS 150 MG/ML pharmaceutical product. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which covers a comprehensive range of branded and...
- SPE2DB25D9363Indefinite Delivery Contract
- SPE2DB25D9363-SPE2DB25FUFSEDelivery Order
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract has a ceiling value of $51,310.04 and is for the delivery of ILARIS 150 MG/ML VIALML, a specialized pharmaceutical product, to support the medical supply needs of military health facilities. The contract has a period of performance through March 26, 2025 and is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. also holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $51.3k | 3/5/25 |